Blood clots are thought to occur in as many as a third of patients hospitalized with COVID-19. In many cases these clots can be deadly, such as pulmonary embolisms—blood clots that travel to the lungs. In fact, in nearly ...
Aug 4, 2022
0
8
New research published in the online journal BMJ Open suggests that men with prostate cancer have a 50% higher risk of developing serious and potentially fatal blood clots during the five years after their cancer diagnosis ...
May 24, 2022
0
49
The U.S. Preventive Services Task Force recommends against use of combined estrogen and progestin and estrogen alone for primary prevention of chronic conditions in postmenopausal persons. These findings form the basis of ...
Apr 19, 2022
0
9
A new Blood Advances study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face an increased risk of developing venous thromboembolism (VTE), or blood clots in the veins, three months ...
Apr 13, 2022
0
9
A study from Sweden published by The BMJ today finds an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after COVID-19 infection, pulmonary embolism (a blood clot in the lung) up to six ...
Apr 6, 2022
0
21
A Kaiser Permanente analysis of pregnant patients who tested positive for the coronavirus found more than double the risk of poor outcomes including preterm birth, venous thromboembolism (blood clot), and severe maternal ...
Mar 21, 2022
0
5
(HealthDay)—Comprehensive clinic-based care may be acceptable for carefully selected adults diagnosed with acute pulmonary embolism in the primary care setting, according to a study published online Jan. 12 in the Journal ...
Jan 25, 2022
0
0
(HealthDay)—For patients with psoriasis, the risk for cancer is increased at the time of or after venous thromboembolism (VTE), according to a research letter published online Jan. 18 in the British Journal of Dermatology.
Jan 24, 2022
0
26
For patients at high risk for venous thromboembolism (VTE) discharged after COVID-19 hospitalization, thromboprophylaxis with rivaroxaban is associated with improved clinical outcomes, according to a study published online ...
Dec 30, 2021
0
12
(HealthDay)—For patients hospitalized with COVID-19, risk factors for postdischarge venous thromboembolism (VTE) include history of VTE, peak D-dimer level greater than 3 µg/mL, and predischarge C-reactive protein level ...
Dec 8, 2021
0
3
